AU2014257267B2 - Veterinary decorin compositions and use thereof - Google Patents

Veterinary decorin compositions and use thereof Download PDF

Info

Publication number
AU2014257267B2
AU2014257267B2 AU2014257267A AU2014257267A AU2014257267B2 AU 2014257267 B2 AU2014257267 B2 AU 2014257267B2 AU 2014257267 A AU2014257267 A AU 2014257267A AU 2014257267 A AU2014257267 A AU 2014257267A AU 2014257267 B2 AU2014257267 B2 AU 2014257267B2
Authority
AU
Australia
Prior art keywords
decorin
veterinary
veterinary decorin
core protein
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014257267A
Other languages
English (en)
Other versions
AU2014257267A1 (en
Inventor
Gregory T. Bleck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions LLC
Original Assignee
Catalent Pharma Solutions LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions LLC filed Critical Catalent Pharma Solutions LLC
Publication of AU2014257267A1 publication Critical patent/AU2014257267A1/en
Application granted granted Critical
Publication of AU2014257267B2 publication Critical patent/AU2014257267B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU2014257267A 2013-04-22 2014-04-22 Veterinary decorin compositions and use thereof Active AU2014257267B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361814405P 2013-04-22 2013-04-22
US61/814,405 2013-04-22
PCT/US2014/034877 WO2014176198A1 (en) 2013-04-22 2014-04-22 Veterinary decorin compositions and use thereof

Publications (2)

Publication Number Publication Date
AU2014257267A1 AU2014257267A1 (en) 2015-09-17
AU2014257267B2 true AU2014257267B2 (en) 2017-03-16

Family

ID=51729463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014257267A Active AU2014257267B2 (en) 2013-04-22 2014-04-22 Veterinary decorin compositions and use thereof

Country Status (6)

Country Link
US (1) US10137168B2 (enExample)
EP (1) EP2989208A4 (enExample)
JP (1) JP2016519110A (enExample)
AU (1) AU2014257267B2 (enExample)
CA (1) CA2907944C (enExample)
WO (1) WO2014176198A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20251064A1 (es) * 2022-04-28 2025-04-09 Biocad Joint Stock Co Acido nucleico aislado que codifica una proteina de fusion basada en fviii-bdd y en un peptido senal heterologo, y uso de la misma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009800A1 (en) * 1991-11-14 1993-05-27 La Jolla Cancer Research Foundation Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
US20120238727A1 (en) * 2011-03-14 2012-09-20 Catalent Pharma Solutions Llc Decorin compositions and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509314B1 (en) * 1988-06-28 2003-01-21 The Burnham Institute Methods of preventing or reducing scarring with decorin or biglycan
US5654270A (en) 1988-06-28 1997-08-05 La Jolla Cancer Research Foundation Use of fibromodulin to prevent or reduce dermal scarring
FI906411A7 (fi) 1988-06-28 1990-12-27 La Jolla Cancer Res Foundation Solujen lisääntymisen esto Decorinilla
US5583103A (en) 1988-06-28 1996-12-10 La Jolla Cancer Research Foundation Inhibition of transforming growth factor beta activity
US6524573B1 (en) * 1997-12-30 2003-02-25 Thomas Jefferson University Method of suppressing tumor cell growth by administering a decorin gene or gene product
AU5087799A (en) 1998-07-06 2000-01-24 Beth Israel Deaconess Medical Center Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis
CN1431911A (zh) * 2000-05-05 2003-07-23 Gtc生物治疗学公司 转基因产生的核心蛋白聚糖
US20040033493A1 (en) 2001-01-31 2004-02-19 Tchernev Velizar T. Proteins and nucleic acids encoding same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009800A1 (en) * 1991-11-14 1993-05-27 La Jolla Cancer Research Foundation Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
US20120238727A1 (en) * 2011-03-14 2012-09-20 Catalent Pharma Solutions Llc Decorin compositions and use thereof

Also Published As

Publication number Publication date
WO2014176198A1 (en) 2014-10-30
CA2907944C (en) 2020-11-03
EP2989208A4 (en) 2016-12-07
US20140315806A1 (en) 2014-10-23
US10137168B2 (en) 2018-11-27
AU2014257267A1 (en) 2015-09-17
JP2016519110A (ja) 2016-06-30
CA2907944A1 (en) 2014-10-30
EP2989208A1 (en) 2016-03-02

Similar Documents

Publication Publication Date Title
CN1087344C (zh) 转化生长因子α－H1
US20170335311A1 (en) Chimeric protein
US20220088136A1 (en) Nerve growth factor mutant
US9963484B2 (en) Polynucleotide encoding a fusion protein for improving skin conditions
JP2003501110A (ja) 肺炎連鎖球菌タンパク質とワクチン
EP2359844A2 (en) Medicaments and proteins based on TGF-beta monomers for the treatment of wounds
US10875903B2 (en) Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof
Zhang et al. Mammary gland expression of antibacterial peptide genes to inhibit bacterial pathogens causing mastitis
EP1008351B1 (en) Carcinostatic agents
WO1993003757A1 (en) Muteins of epidermal growth factor exhibiting enhanced binding at low ph
JPWO1999010001A1 (ja) 制がん剤
CN101914561B (zh) 一种具有抗菌和修复功能的融合蛋白及其生产方法和应用
AU2014257267B2 (en) Veterinary decorin compositions and use thereof
CZ98297A3 (cs) Způsob purifikace keratinocytových růstových faktorů
EP0624645A1 (en) Human chondromodulin-I protein
AU2609799A (en) Method for treating acute intermittent porphyria (aip) and other porphyric diseases
EP1080111B1 (en) The induction of antiobiotic peptides by lait (scd14) protein
MXPA04011405A (es) Muteinas del factor de crecimiento placentario tipo 1, metodo de preparacion y aplicacion.
KR20060017348A (ko) 세포도입성 보톡신 융합단백질
JP2002508151A (ja) 哺乳類乳汁成長因子
US9371523B2 (en) Cell migration regulator
EP0686194A1 (fr) Facteurs de croissance de la famille de l'harp, procede d'obtention et applications
CN115710307A (zh) 蝎毒素及其突变体在抗癫痫中的应用
JP2002532060A (ja) 新規なヒトリゾチーム遺伝子、それによりコードされたポリペプチド、およびそれらの作製方法
KR20010066967A (ko) 아르기닌 디이미네이즈를 유효성분으로 하는 혈관신생억제제

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)